Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence

Diseases of the Colon and Rectum

Volumn 44, Issue 11, 2001, Pages 1682-1688

  Burdy, G ^a   Panis, Y ^a   Alves, A ^a   Nemeth, J ^a   Lavergne Slove, A ^a   Valleur, P ^a  

^a Lariboisiere Hospital   (France)

Author keywords

Adjuvant chemotherapy; Colon cancer; Tumor recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MUCIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; COLON CANCER; COLON RESECTION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0035205821     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02234390     Document Type: Article

References (38)

1. Survival of patients with stage B2 colon carcinoma: The gastrointestinal tumor study group experience
2. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators
3. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
4. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer
5. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes B2 colon cancer
6. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) investigators
7. Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death
8. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer: Findings from the NSABP clinical trials
9. Regression analysis of prognostic factors in colorectal cancer after curative resections
10. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil
11. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
12. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
13. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
14. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, C-04)
15. Prognosis in patients with obstructing colorectal carcinoma
16. Prognostic indicators of colon tumors: The gastrointestinal tumor study group experience
17. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer
18. Local turnout invasion as a prognostic factor in colorectal cancer
19. Vascular and neural invasion in colorectal carcinoma: Incidence and prognostic significance
20. A prospective clinicopathologic study of venous invasion in colorectal cancer
21. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: Correlation with long-term survival
22. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer: Results from NSABP clinical trials
23. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: A multivariate analysis of 572 patients
24. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis
25. Assessing the effectiveness of mesorectal excision in rectal cancer: Prognostic value of the number of lymph nodes found in resected specimens
26. Immunomorphological features of prognostic significance in Dukes' stage B colorectal carcinoma
27. Allelic loss of the chromosome 18q and prognosis in colorectal cancer
28. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
29. The DCC protein and prognosis in colorectal cancer
30. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma
31. Five-year prospective study of DNA tumor ploidy and colorectal cancer survival
32. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: A prospective flow cytometric study
33. DNA index as a significant predictor of recurrence in colorectal cancer
34. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
35. Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma
36. Micrometastases and survival in stage II colorectal cancer
37. Urokinasetype plasminogen activator and outcome in Dukes' B colorectal cancer
38. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer